Yi-Hsuan Shih

ORCID: 0000-0003-2029-8230

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study”.

Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0490

N/A

0.269DataRank · unranked

5 citations

Yi-Hsuan Shih, John H. Huber, Mei Wang, Eric J. Feuer, Ruth Etzioni +3 more

From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.7556

N/A

0.269DataRank · unranked

5 citations

Mei Wang, Yi-Hsuan Shih, John H. Huber, Mark A. Fiala, Rong Wang +6 more

Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.07.017

N/A

0DataRank · unranked

0 citations

Mengmeng Ji, Yi-Hsuan Shih, John H. Huber, Mei Wang, Kimberly J. Johnson +6 more